Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
So if we’re right, each former human is now essentially a radio transmitter and receiver. One plurb sends out a signal that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback